ÂÜÀòÂÒÂ×

Nicolas Fouché has 21 years of pharmaceutical and biotechnology experience with the Boston Consulting Group (BCG), AstraZeneca, and most recently Gilead. He joined Aimmune in early 2020 as General Manager, France and U.K. to prepare for the launch of PALFORZIA; creating country teams and supporting reimbursement efforts before being promoted in December 2020 to his current position and undertaking the same launch activities across Europe and other geographies in order to bring PALFORZIA to patients worldwide.

Prior to Aimmune, Mr. Fouché’s career spanned positions in Marketing, Sales, Business Development, Strategic Planning, Business Operations and General Management; starting initially as an advisor to pharmaceutical companies at BCG, and then in-market positions in France, the U.K. and Japan, and regional roles across Europe, the Middle East and Africa (EMEA) and Central & Eastern Europe; overseeing dozens of launches of Gilead’s Hepatitis C and HIV medicines; and setting up infrastructures for patients to receive life-saving viral treatment. Mr. Fouché is French and holds a Master of Business Administration from Ecole Supérieure des Sciences Economiques et Commerciales (ESSEC).